祁无敌
Lv8
8665 积分
2020-10-14 加入
-
Safety, tolerance, pharmacokinetic and pharmacodynamic properties of thrombopoietin mimetic peptide for injection in Chinese healthy volunteers: a randomized, placebo-controlled, double-blind study
1个月前
已完结
-
All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial
2个月前
已完结
-
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
4个月前
已完结
-
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
-
[A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor]
1年前
已完结
-
Recombinant human thrombopoietin increases platelet count in severe thrombocytopenic patients with hepatitis B‐related cirrhosis: Multicentre real‐world observational study
1年前
已完结
-
中国50岁以上表观健康人群多中心外周血脂蛋白相关磷脂酶A2质量浓度参考区间研究
2年前
已完结
-
EASL临床实践指南:预防和治疗肝硬化出血和血栓
2年前
已完结
-
慢性肝病相关血小板减少症管理策略
2年前
已完结
-
中国成人血小板减少症诊疗专家共识
2年前
已完结